Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
Essential Oil Isolates Market Review:
The market research report on the Global market for isolates from essential oils The company offered by Straits Research...